
11 - 50 employees
Founded 2022
🧬 Biotechnology
🔬 Science
Biotechnology • Science
Belay Diagnostics is a clinical diagnostics company that develops and offers proprietary cerebrospinal fluid (CSF) liquid biopsy genomic tests (Belay Summit, Belay Ascent, Belay Vantage) to help clinicians detect, classify, monitor, and manage primary and metastatic central nervous system malignancies. Their assays provide validated, minimally invasive alternatives to cytology, MRI, and invasive tissue biopsy by delivering genomic profiling to inform diagnosis, treatment selection, and disease monitoring. The company also provides clinician- and patient-facing portals, sample handling guidance, and reporting to support test ordering and clinical decision-making.
🔥 7 minutes ago
Account Manager at Belay Diagnostics, expanding presence in high-volume hospitals. Fostering relationships with lab teams and clinical operations to increase test utilization.